TDMS Study 60855-02 Pathology Tables
NTP Experiment-Test: 60855-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: 18-33 DAYS BETA-BROMO-BETA-NITROSTYRENE Date: 10/19/04
Route: GAVAGE Time: 14:15:11
Facility: BIORELIANCE
Chemical CAS #: 7166-19-0
Lock Date: 04/23/92
Cage Range: All
Reasons For Removal: All
Removal Date Range: All
Treatment Groups: Include All
a Number of animals examined microscopically at site and number of animals with lesion
Page 1
NTP Experiment-Test: 60855-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: 18-33 DAYS BETA-BROMO-BETA-NITROSTYRENE Date: 10/19/04
Route: GAVAGE Time: 14:15:11
____________________________________________________________________________________________________________________________________
B6C3F1 MICE FEMALE CONTROL 0.037 0.075 0.150 0.300 0.600
G/KG G/KG G/KG G/KG G/KG
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY
Animals Initially in Study 10 10 10 10 10 10
Early Deaths
Dosing Accident 1
Natural Death 6
Moribund Sacrifice 4
Survivors
Terminal Sacrifice 10 10 10 9 10
Animals Examined Microscopically 10 10 10 10 10 10
____________________________________________________________________________________________________________________________________
ALIMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
CARDIOVASCULAR SYSTEM
None
____________________________________________________________________________________________________________________________________
ENDOCRINE SYSTEM
None
____________________________________________________________________________________________________________________________________
GENERAL BODY SYSTEM
None
____________________________________________________________________________________________________________________________________
GENITAL SYSTEM
None
____________________________________________________________________________________________________________________________________
HEMATOPOIETIC SYSTEM
None
____________________________________________________________________________________________________________________________________
Page 2
NTP Experiment-Test: 60855-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: 18-33 DAYS BETA-BROMO-BETA-NITROSTYRENE Date: 10/19/04
Route: GAVAGE Time: 14:15:11
____________________________________________________________________________________________________________________________________
B6C3F1 MICE FEMALE CONTROL 0.037 0.075 0.150 0.300 0.600
G/KG G/KG G/KG G/KG G/KG
____________________________________________________________________________________________________________________________________
INTEGUMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
MUSCULOSKELETAL SYSTEM
None
____________________________________________________________________________________________________________________________________
NERVOUS SYSTEM
None
____________________________________________________________________________________________________________________________________
RESPIRATORY SYSTEM
None
____________________________________________________________________________________________________________________________________
SPECIAL SENSES SYSTEM
None
____________________________________________________________________________________________________________________________________
URINARY SYSTEM
None
Page 3
NTP Experiment-Test: 60855-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: 18-33 DAYS BETA-BROMO-BETA-NITROSTYRENE Date: 10/19/04
Route: GAVAGE Time: 14:15:11
____________________________________________________________________________________________________________________________________
B6C3F1 MICE MALE CONTROL 0.037 0.075 0.150 0.300 0.600
G/KG G/KG G/KG G/KG G/KG
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY
Animals Initially in Study 10 10 10 10 10 10
Early Deaths
Natural Death 1 4
Moribund Sacrifice 6
Survivors
Terminal Sacrifice 9 9 9 10 9
Accidently Killed 1 1 1
Animals Examined Microscopically 10 10 10 10 10 10
____________________________________________________________________________________________________________________________________
ALIMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
CARDIOVASCULAR SYSTEM
None
____________________________________________________________________________________________________________________________________
ENDOCRINE SYSTEM
None
____________________________________________________________________________________________________________________________________
GENERAL BODY SYSTEM
None
____________________________________________________________________________________________________________________________________
GENITAL SYSTEM
None
____________________________________________________________________________________________________________________________________
HEMATOPOIETIC SYSTEM
None
____________________________________________________________________________________________________________________________________
Page 4
NTP Experiment-Test: 60855-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02
Study Type: 18-33 DAYS BETA-BROMO-BETA-NITROSTYRENE Date: 10/19/04
Route: GAVAGE Time: 14:15:11
____________________________________________________________________________________________________________________________________
B6C3F1 MICE MALE CONTROL 0.037 0.075 0.150 0.300 0.600
G/KG G/KG G/KG G/KG G/KG
____________________________________________________________________________________________________________________________________
INTEGUMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
MUSCULOSKELETAL SYSTEM
None
____________________________________________________________________________________________________________________________________
NERVOUS SYSTEM
None
____________________________________________________________________________________________________________________________________
RESPIRATORY SYSTEM
None
____________________________________________________________________________________________________________________________________
SPECIAL SENSES SYSTEM
None
____________________________________________________________________________________________________________________________________
URINARY SYSTEM
None
Page 5
------------------------------------------------------------
---------- END OF REPORT ----------
------------------------------------------------------------